Compare Supplements

No validated longevity dose. Senolytic research uses intermittent 'hit-and-run' D+Q (e.g. dasatinib 100 mg + quercetin for ~2–3 days, repeated periodically) — investigational and only appropriate under medical supervision. Approved leukemia dosing is continuous and higher.

Any time

Oral dasatinib + quercetin (D+Q)

750mg

With meals · with food

Fisetin capsules or powder

• Pregnancy / breastfeeding
• Active bleeding or significant thrombocytopenia
• Significant cardiac disease / QT prolongation

• CYP3A4 inhibitors / inducers
• Acid-reducing agents (PPIs/H2/antacids)
• Anticoagulants / antiplatelets

• Pregnancy (affects cell processes)

• Blood thinners